Nicotine and cognition in young and aged nonhuman primates

Nicotinic Receptors in the Nervous System

Volumn , Issue , 2001, Pages 179-198

  Buccafusco, Jerry J ^a   Terry, Alvin V ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958296476     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (72)

1. Elrod, K., Buccafusco, J. J., and Jackson, W. J., Nicotine enhances delayed matchingto-sample performance by primates, Life Sci., 43, 277, 1988.
2. Warburton, D. M., Wesnes, K., Shergold, K., and James, M., Facilitation of learning and state dependency with nicotine, Psychopharmacology, 89, 55, 1986.
3. Elrod, K. and Buccafusco, J. J., Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats, J. Pharmacol. Exp. Ther., 258, 403, 1991.
4. Paule, M. G., Bushnell, P. J., Maurissen, J. P. J., Wenger, G. R., Buccafusco, J. J., Chelonis, J. J., and Elliott, R., Symposium overview: the use of delayed matchingto-sample procedures in studies of short-term memory in animals and humans, Neurotoxicol. Teratol., 20, 493, 1998.
5. Wilkie, G. I., Hutson, P., Sullivan, J. P., and Wonnacott, S., Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes, Neurochemi. Res., 21, 1141, 1996.
6. Reuben, M. and Clarke, P. B., Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes, Neuropharmacology, 39, 290, 2000.
7. Wesnes, K. and Warburton, D. M., Effects of scopolamine and nicotine on human rapid information processing performance, Psychopharmacology, 82, 147, 1984.
8. Wesnes, K. and Revell, A., The separate and combined effects of scopolamine and nicotine on human information processing, Psychopharmacology, 84, 5, 1984.
9. Terry, A. V., Jr., Buccafusco, J. J., and Jackson, W. J., Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance by monkeys, Pharmacol. Biochem. Beh., 45, 925, 1993.
10. Levin, E. D., Nicotinic systems and cognitive function, Psychopharmacology, 108, 417, 1992.
11. Buccafusco, J. J., and Yang, X-H., Mechanism of the hypertensive response to central injection of nicotine in conscious rats, Brain Res. Bull., 32, 35, 1993.
12. Rupniak, N. M., Steventon, M. J., Field, M. J., Jennings, C. A., and Iverson, S. D., Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects, Psychopharmacology, 99, 189, 1989.
13. Bartus, R.T., On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis, Exp. Neurol., 163, 495, 2000.
14. Buccafusco, J. J. and Terry, A. V., Jr., Multiple CNS targets for eliciting beneficial effects on memory and cognition, J. Pharmacol. Exp. Ther., (in press).
15. Jackson, W. J. and Buccafusco, J. J., Clonidine enhances delayed matching-to-sample performance by young and aged monkeys, Pharmacol. Biochem., Beh., 39, 79, 1991.
16. Terry, A. V., Jr., Jackson, W. J., and Buccafusco, J. J., Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys, Cerebral Cortex, 3, 304, 1993.
17. 3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys, NeuroReport, 8, 49, 1996.
18. Bartolomeo, A. C., Morris, H., Buccafusco, J. J., Kille, N., Rosenzweig-Lipson, S., Husbands, M. G., Sabb, A. L., Abou-Gharbia, M., Moyer, J. A., and Boast, C. A., The preclinical pharmacological profile of WAY-132983, a potent M1 Preferring Agonist, J. Pharmacol. Exp. Ther., 292, 584, 2000.
19. Hironaka, N., Miyata, H., and Ando, K., Effects of psychoactive drugs on short-term memory in rats and rhesus monkeys, Japan. J. Pharmacol., 59, 113, 1992.
20. Witte, E. A., Davidson, M. C., and Marrocco, R. T., Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance, Psychopharmacology, 132, 324, 1997.
21. Hudzik, T. J. and Wenger, G. R., Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey, J. Pharmacol. Exp. Ther., 265, 120, 1993.
22. Schneider, J. S., Tinker, J. P., Van Velson, M., Menzaghi, F., and Lloyd, G. K., Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys, J. Pharmacol. Exp. Ther., 290, 731, 1999.
23. Buccafusco, J. J. and Jackson, W. J., Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys, Neurobiol. Aging, 12, 233, 1991.
24. Buccafusco, J. J., Jackson, W. J., Terry, Jr., A. V., Marsh, K. C., Decker, M. W., and Arneric, S. P., Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement, Psychopharmacology, 120, 256, 1995.
25. Buccafusco, J. J., Jackson, W. J., Gattu, M., and Terry, A. V., Jr., Isoarecolone-induced memory enhancement in monkeys: Role of nicotinic receptors, NeuroReport, 6,1223, 1995.
26. Berry, A. V., Jr., Buccafusco, J. J., and Prendergast, M. A., Dose-specific improvements in memory-related task performance by rats and aged monkeys administered the nicotinic-cholinergic antagonist mecamylamine, Drug Develop. Res., 47, 127, 1999.
27. Azuma, R., Komuro, M., Korsch, B. H., Andre, J. C., Onnagawa, O., Black, S. R., and Mathews, J. M., Metabolism and disposition of GTS-21, a novel drug for Alzheimer’s disease, Xenobiotica, 29, 747, 1999.
28. van Haaren, R., Anderson, K. G., Haworth, S. C., and Kern, W. R., GTS-21, a mixed nicotinic receptor agonist/antagonist, does not affect the nicotine cue, Pharmacol. Biochem. Beh., 64, 439, 1999.
29. Briggs, C. A., Anderson, D. J., Brioni, J. D., Buccafusco, J. J., Buckley, M. J., Campbell, J. E., Decker, M. W., Donnelly-Roberts, D., Elliott, R. L., Holladay, M. W., Hui, Y-H., Jackson, W. J., Kim, D. J. B., Marsh, K. C., O-Neill, A., Prendergast, M. A., Ryther, K. B., Sullivan, J. P., and Arneric, S. P., Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21. In vitro and in vivo, Pharmacol. Biochem. Beh., 57, 231, 1997.
30. Terry, A. V., Jr., and Clarke, M. S. F., Nicotine stimulation of nerve growth factor receptor expression, Life Sci., 55, PL 91, 1994.
31. Jonnala, R. R. and Buccafusco, J. J., Nicotine increases the expression of TrkA receptors on differentiated PC12 cells, Soc. Neurosci. Abs., 24, 1340, 1998.
32. Grady, S. R., Marks, M. J., Wonnacott, S., and Collins, A. C., Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum, J. Neurochem., 59, 848, 1992.
33. Granon, S., Poucet, B., Thinus-Blanc, C., Changeux, J. P., and Vidal, C., Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing, Psychopharmacology, 119,139, 1995.
34. Rowell, P. P. and Wonnacott, S., Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes, J. Neurochem., 55, 2105, 1990.
35. Collins, A. C., Romm, E., and Wehner, J. M., Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors, Brain Res. Bull., 25, 373, 1990.
36. Yang, X. H. and Buccafusco, J. J., Comparison of the ability of direct and indirectacting nicotinic agonists to induce nicotinic receptor up-regulation in rat cerebral cortex, Drug Devel. Res., 31, 95, 1994.
37. Clarke, P. B. S. and Reuben, M., Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release, Br. J. Pharmacol., 117, 607, 1996.
38. James, J. R., Villanueva, H. F., Johnson, J. H., Arezo, S., and Rosecrans, J. A., Evidence that nicotine can acutely desensitize central nicotinic acetylcholinergic receptors, Psychopharmacology, 114, 456, 1994.
39. Damaj, M. I., Welch, S. P., and Martin, B. R., Characterization and modulation of acute tolerance to nicotine in mice, J. Pharmacol. Exp. Ther., 277, 454, 1996.
40. Rowell, P. P. and Duggan, D. S., Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine, Neuropharmacology, 37,103, 1998.
41. Levin, E. D. and Rose, J. E., Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats, Behav. Pharmacol., 1, 511, 1990.
42. Woodruff-Pak, D. S. and Hinchliffe, R. M., Mecamylamine-or scopolamine-induced learning impairment: ameliorated by nefiracetam, Psychopharmacology, 131,130, 1997.
43. Newhouse, P. A., Potter, A., Corwin, J., and Lenox, R., Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior, Neuropsychopharmacology, 10, 93, 1994.
44. O’Dell, T. J. and Christensen, B. N., Mecamylamine is a selective noncompetitive antagonist of n-methyl-d-aspartate and aspartate-induced currents in horizontal cells dissociated from catfish retina, Neuroscience Lett., 94, 93, 1988.
45. Freund, R. K., Jungschaffer, D. A., and Collins, A. C., Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not other nicotinic antagonists, Brain Res., 511, 187, 1990
46. Ropert, N. and Krnjevic, K., Pharmacological characteristics of facilitation of hippocampal population spikes by cholinomimetics, Neuroscience, 7, 1963, 1982.
47. Decsi, L. and Karmos-Varszegi, M., Fear and escape reaction evoked by the intrahypothalamic injection of d-tubocurarine in unrestrained cats, Acta Physiologica. Acad. Sci. Hungary, 36, 95, 1969.
48. Buccafusco, J. J. and Brezenoff, H. E., Opposing influences on behavior mediated by muscarinic and nicotinic receptors in the rat posterior hypothalamic nucleus, Psychopharmacology, 67, 249, 1980.
49. Elia, J., Ambrosini, P. J., and Rapoport, J. L., Treatment of attention-deficit-hyperactivity disorder, New Eng. J. Med., 340, 780, 1999.
50. Elia, J., Drug treatment for hyperactive children. Therapeutic guidelines, Drugs, 46, 863, 1993.
51. Jones, G. M., Sahakian, B. J., Levy, R., Warburton, D. M., and Gray, J., A. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer’s disease, Psychopharmacology, 108, 485, 1992.
52. Newhouse, P. A., Potter, A., Corwin, J., and Lenox, R., Acute nicotinic blockade produces cognitive impairment in normal humans, Psychopharmacology, 108, 480, 1992.
53. Le Houezec, J., Halliday. R., Benowitz, N. L., Callaway, E., and Naylor, H., A low dose of subcutaneous nicotine improves information processing in nonsmokers, Psychopharmacology, 114, 628, 1994.
54. Levin, E. D. and Simon, B. B., Nicotinic acetylcholine involvement in cognitive function in animals, Psychopharmacology, 138, 217, 1998.
55. Wilens, T. E., Biederman, J., Spencer, T. J., Bostic, J., Prince, J., Monuteaux, M. C., Soriano, J., Fine, C., Abrams, A., Rater, M. and Polisner, D. A., pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder, Am. J. Psych., 156, 1931, 1999.
56. Prendergast, M. A., Jackson, W. J., Terry, A. V. Jr., Kille, N. J., Arneric, S. P., Decker, M. W., and Buccafusco, J. J., Age-related differences in distractibility and response to methylphenidate in monkeys, Cerebral Cortex, 8, 164, 1998.
57. Prendergast, M. A, Jackson, W. J., Terry, A. V. Jr., Decker, M. W., Arneric, S. P., and Buccafusco, J. J., Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys, Psychopharmacology, 136, 50, 1998.
58. Terry, A. V. Jr, Buccafusco, J. J., Menzaghi, F., and Lloyd, G. K., Nicotinic-cholinergic receptor (nAChR) agonist SIB 1553A reduces distractibility in adult macaques, Soc. Neurosci. Abs., 25, 1981, 1999.
59. Price, D. L. and Sisodia, S. S., Cellular and molecular biology of Alzheimer’s disease and animal models, Ann. Rev. Med., 45, 435, 1994.
60. Voytko, M. L., Nonhuman primates as models for aging and Alzheimer’s disease, Lab. Animal Sci., 48, 611, 1998.
61. Oscar-Berman, M. and Bonner, R. T., Matching-and delayed matching-to-sample performance as measures of visual processing, selective attention, and memory in aging and alcoholic individuals, Neuropsychologia, 23, 639, 1985.
62. Perryman, K. M. and Fitten, L. J., Delayed matching-to-sample performance during a double blind trial of tacrine (THA) and lecithin in patients with Alzheimer’s disease, Life Sci., 53, 479, 1993.
63. Faraday, M. M., Rahman, M. A., Scheufele, P. M., and Grunberg, N. E., Nicotine administration impairs sensory gating in Long-Evans rats, Pharmacol. Biochem. Behav., 61, 281, 1998.
64. Shieh, K.R. and Pan, J. T., Sexual differences in the diurnal changes of tuberinfundibular dopaminergic neuron activity in the rat - role of cholinergic control, Biol. Reproduc., 54, 987, 1996.
65. Yilmaz, O., Kanit, L., Okur, B. E., and Pogun, S., Effects of nicotine on activeavoidance learning in rats - sex-differences, Behav. Pharmacol., 8, 253, 1997.
66. Chiari, A. and Eisenach, J. C., Effects of RJR 2403, a selective nicotinic agonist, in male and female rats, FASEB J., 12, A158, 1998.
67. Rojas, N. L., Killen, J. D., Haydel, K. F., and Robinson, T. N., Nicotine dependence among adolescent smokers, Arch. Pediat. Adoles. Med., 152, 151, 1998.
68. Gritz, E. R., Nielsen, I. R., and Brooks, L. A., Smoking cessation and gender: the influence of physiological and psychological, and behavioral factors, J. Am. Med. Womens Assoc., 51, 35, 1996.
69. Perkins, K. A., Sanders, M., D-Amico, D., and Wilson, A., Nicotine discrimination and self-administration in humans as a function of smoking status, Psychopharmacology, 131, 361, 1997.
70. Perkins, K. A., Sexton, J. E., and DiMarco, A., Acute thermogenic effects of nicotine and alcohol in healthy male and female smokers, Physiol. Behav., 60, 305, 1996.
71. Girdler, S. S., Jamner, L. D., Jarvik, M., Soles, J. R., and Shapiro, D., Smoking status and nicotine administration differentially modify hemodynamic stress reactivity in men and women, Psychosom. Med., 59, 294, 1997.
72. Buccafusco, J. J., Jackson, W. J., Jonnala, R. R., and Terry, A. V., Jr., Differential improvement in memory-related task performance to nicotine by aged male and female rhesus monkeys, Behav. Pharmacol., 10, 681, 1999.